Synthesis, Biological Screening and in Silico Studies of Chalcone Based Novel Phenyl Urea Derivatives as Potential Antihyperglycemics
Aim: Current work was aimed to explore the effect of synthesized novel chalcone based1-(4"-methoxyphenyl)-3-{4- [(2E)-3-phenylprop-2-enoyl] phenyl} ureaderivatives, on adult male Wister rats in an experimental model of type 2 diabetes.
Methods: Type 2 Diabetes was induced in overnight fasted rats by a high fat diet followed by a single intraperitoneal injection of low dose streptozotocin (35mg/kg body weight) leading to hyperglycemia and considerable augmentation in blood urea nitrogen and creatinine levels. Treatment with compounds 2(a-d) and 3(a-c)(dose; 30mg/kg) continued for 28 days followed by oral glucose tolerance test. Docking studies of synthesized compounds with ligand binding domain of the human peroxisome proliferator activated receptor gamma-2(2PRG) were performedto correlate the antihypergycemic activity for possible mode of action.
Result: Oral administration of compounds 2(a-d) and 3(a-c)in 35mg/kg for 4 weeks reduced blood glucose level significantly by 68-71% and 71-75% respectively comparable to that of glipizide(80%) in a dose of 1mg/kg/day coupled with significant reduction (p≤0.05) in the increased blood urea nitrogen and serum triglyceride level. Compound 2c have been found most active on the PPAR gamma receptor displaying docking score (-21) comparable to reference ligands Rosiglitazone and pioglitazone.
Conclusion: This observation indicates that chalcone based novel phenylureas have the potential to be an effective antihypergycemic agent with probable PPAR gamma agonistic action.
Keywords
- http://timesofindia.indiatimes.com/life-style/health-fitness/healthnews/ India-is-thediabetes- capital-of-the-world/articleshow/50753461.cms,Malik R, 2016, [Cited 2016,Jan 28]
- Gisela W, Insulin and insulin resistance, Clin. Biochem. Rev.2010; 26:119-139.
- MahapatraDK, AsatiV, BhartiSK. Chalcones and their therapeutic targets for the management of diabetes: structural and pharmacological perspectives. Eur. J Med. Chem.2015; 92: 839-865.
- JawaleDV, PratapUR, RahujaN,SrivastavaAK, ManeRA.Synthesis and antihyperglycemic evaluation of new2,4-thiazolidinediones having biodynamic arylsulfonylureamoieties,Bioorg. & Med. Chem. Lett.2012; 22:436-439.
- ShuklaP, SinghAB, SrivastavaAK , PratapR. Chalcone based aryloxypranolamines as potential antihyperglycemic agent, Bioorg.med chem.2007;17: 799-802.
- SeoWD, JinHK, KangJE, RyuHW, LongMJC, LeeHS Yang MS, ParkKH, Sulfonamide chalcone as a new class of alpha-glucosidase inhibitors, Bioorg. Med. Chem. Lett.2005;15: 5514-5516.
- KharbandaC, AlamMS, HamidH, JavedK, DhulapA, BanoS, AliY, Antidiabetic effect of novel benzenesulfonylureas as PPAR-γ agonists and their anticancer effect, Bioorg.Med.Chem.Lett.2015;25: 4601-4605.
- KharbandaC, AlamMS, HamidH, JavedK, DhulapA, BanoS, Ali Y, Novel benzenesulfonylureas containing thiophenylpyrazoline moiety as potential antidiabetic andanticancer agents, Bioorg.Med.chem.Lett.2015;24: 52985303.
- FrankRL,SmithPV.Org. Synth.1948;28: 89, DOI: 10.15227/orgsyn.028.0089, [Accessed on 20 May, 2014].
- Vasudeva RA, Yejella RP, Annapurna A, Guntuku GS, Doddi BR, Vutla VR, Anagani SR et.al, Synthesis, characterization and biological evaluation of some novel 2,4- thiazolidinediones as potential cytotoxic, antimicrobial and antihyperglycemic agents, Bioorg. Med. Chem. Lett.2012; 22:6442–6450.
- Bandgar BP, Gawande SS, Bodade RG,Totre JV, Khobragade CN, Synthesis and biological evaluation of simple methoxylated chalcones as anticancer, antiinflammatory and antioxidant agents,Bioorg. Med. Chem.2010; 18:1364–1370.
- SkovsoS. Modeling type 2 diabetes in rats using high fat diet and streptozotocin.J Diabetes Investig.2014; 5: 349-358,DOI:10.1111/jdi.12235.
- L Crane, Anastassiadou M, Salomé Ehage, StiglianiJL, Baziard-Mouysset G, Payard, JM..Leger M, Bizot-Espiard JG, Ktorza A., Imidazoline derivatives with potent antihyperglycemic activity in a rat model of type 2 diabetes, Bioorg Med chem.2006;14:7419-33.
- Roy S, Majumdar S, Singh AK, Ghosh B, Ghosh N, Manna S, Chakraborty S, Mallick S, Synthesis, Characterization, Antioxidant Status, and Toxicity Study of Vanadium–Rutin Complex in Balb/c Mice, Biol. Trace. Elem. Res.2015; 166 (2):183-200.
- Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening.Pharmacol Res, 2005; 52: 313–320.
- Saha HR, Sarkar BC, Khan SA, Sana NK, Choudhury S, A comparative study of thyroid hormone and lipid status in diabetic and non diabetic adults.Open. Access. Sci.Reports.2012; 1(9):1–5.
- HenryNG, Yuan-LiZ, AntonioH, Regulation of plasma triglycerides ininsulin resistance and diabetes. Arch Med Res.2005; 36: 232–240.
- Oliveira HC, Dos S, Grigulo MP, Lima LL, Martins DTO, Lima JCS, Stoppiglia LF, Lopes, Kawashita CF, Hypoglycemic and antihyperglycemic effect of begonia malabarica in STZrats, N.F. J Ethnopharmacol.2008;115: 515 –519.
- Jangra M, Sharma S, Kumar M, Evaluation of antihyperglycemic activity of dodonaea viscosa leaves in normal and stzdiabetic rats.Int. J Pharm. Pharm. Sci.2011;3: 69-74.
- TsakovskaI, Al SharifM, Alov P, Diukendjieva A, Fioravanzo E, CroninMTD, Pajeva I, Molecular Modelling Study of the PPARγ Receptor in Relationto the Mode of Action/Adverse Outcome Pathway Framework for Liver Steatosis,Int. J. Mol. Sci.2014;15: 7651-7666.
- GuaschL, Sala E, Castell-Auví A, CedoL, Liedl KR, Wolber G, Muehlbacher M, MuleroM,PinentM,ArdévolA, Identification of PPARgamma partial agonists of natural origin (I): Development of a virtual screening procedure and in vitro validation. PLoS One.2012; 7: e50816.
- Jung SH, Park SY, Kim-pak Y, Lee HK, Park KS, Shin KH OhuchiK, Keum SR, Lim SS, Synthesis and PPAR-γLigand-Binding Activity of the New Series of 2Hydroxychalcone and Thiazolidinedione Derivatives,Chem. Pharm. Bull.2006;54: 368—371.
- HI Kim,YH Ahn, Role of Peroxisome Proliferator–Activated Receptor in the glucosesensing apparatus of liver and cells, Diabetes.2004; 1:S60-65.
Abstract Views: 202
PDF Views: 87